# Imicryl Dis Malzemeleri Sanayi VE Ticaret AS

- Location (FDA's records): Konya, TR
- FDA decisions: 5 (2019–2022): 5 510(k) clearances
- Product codes: EMA (2), EBF (2), KLE (1)
- 510(k) review time since 2016: median 258 days, against 163 for FDA's reviews in the same codes and years (1 of 5 faster)
- Predicates its devices cite: 6 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Silmet, Ltd.: 2 (https://510kreport.com/company/silmet)
- Kuraray Noritake Dental, Inc.: 1 (https://510kreport.com/company/kuraray-noritake-dental)
- Kerr Corporation: 1 (https://510kreport.com/company/kerr)
- Ivoclar Vivadent, Inc.: 1 (https://510kreport.com/company/ivoclar-vivadent)
- Kuraray Medical, Inc.: 1 (https://510kreport.com/company/kuraray-medical)

## Recent decisions
- K213609: NOVA RESIN dual cure, self adhesive resin cement (Aug 9, 2022)
- K220077: IMICRYL Composite, Composite Flow Materials (Aug 9, 2022)
- K210473: Nova Glass Cements (Nova Glass L, Nova Glass F, Nova Glass LC, Nova Glass BF, Nova Glass L Plus) (Nov 2, 2021)
- K192913: R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose (Jan 19, 2021)
- K192178: R&D Series Nova Compo N (Dec 20, 2019)

Source page: https://510kreport.com/company/imicryl-dis-malzemeleri-sanayi-ve-ticaret